- Report
- January 2025
- 175 Pages
Global
From €4095EUR$4,490USD£3,452GBP
- Report
- March 2025
- 145 Pages
Global
From €2735EUR$2,999USD£2,306GBP
- Report
- January 2025
- 200 Pages
Global
From €5427EUR$5,950USD£4,575GBP
- Report
- May 2025
- 93 Pages
Global
From €5336EUR$5,850USD£4,498GBP
- Report
- April 2025
- 200 Pages
Global
From €4095EUR$4,490USD£3,452GBP
- Report
- June 2024
- 160 Pages
Global
From €4059EUR$4,450USD£3,421GBP
- Report
- January 2025
- 90 Pages
United States
From €4515EUR$4,950USD£3,806GBP
- Report
- June 2024
- 51 Pages
China
From €1003EUR$1,100USD£846GBP
- Report
- October 2022
- 71 Pages
Global
- Report
- October 2023
- 142 Pages
Asia Pacific
From €3147EUR$3,450USD£2,652GBP
- Report
- April 2024
- 140 Pages
Global
From €4514EUR$4,949USD£3,805GBP
- Report
- November 2021
- 145 Pages
Global
From €2370EUR$2,598USD£1,998GBP
€3386EUR$3,712USD£2,854GBP
- Book
- August 2019
- 264 Pages
- Book
- April 2018
- 528 Pages
- Book
- April 2018
- 464 Pages
- Book
- January 2018
- 144 Pages

Aortic Stenosis is a condition in which the aortic valve of the heart narrows, restricting the flow of blood from the left ventricle to the aorta. This can lead to symptoms such as chest pain, shortness of breath, and fatigue. In severe cases, it can cause heart failure and sudden death. Treatment for Aortic Stenosis typically involves either a balloon valvuloplasty or aortic valve replacement.
The Aortic Stenosis market is a subset of the larger Cardiology market, which includes treatments for a variety of heart conditions. Aortic Stenosis treatments are typically used to improve the quality of life of patients, reduce symptoms, and prevent further complications.
Some companies in the Aortic Stenosis market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and St. Jude Medical. Show Less Read more